Press release
Asia-Pacific Pain Management Drugs Market to hit US$31,304.67 million by 2033 | Major Companies 2025 - Sun Pharmaceutical Industries Ltd, Kalbe Farma, Hisamitsu Pharmaceutical Co.
Asia-Pacific Pain Management Drugs Market
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/asia-pacific-pain-management-drugs-market?sp
Asia-Pacific
Recent Launches and Investments
✅ In July 2025, Pfizer launched a new non-opioid pain management drug in Australia targeting chronic pain patients. The therapy provides long-lasting relief with a lower risk of side effects. It addresses growing demand for safer pain management solutions.
✅ In March 2025, Novartis introduced an innovative analgesic formulation in India for post-operative and neuropathic pain management. The launch included $12 million in regional R&D investment. It aims to improve patient outcomes and accessibility in emerging markets.
Mergers and Acquisitions
✅ In August 2025, Teva Pharmaceuticals acquired a regional pain management drug manufacturer in Southeast Asia. The acquisition strengthens its portfolio and production capabilities. It supports the expansion of advanced pain therapies across the region.
✅ In May 2025, Eli Lilly partnered with a local biopharma firm to co-develop next-generation pain management drugs. The collaboration focuses on non-opioid therapies with enhanced efficacy. It targets hospitals and specialty clinics in Asia-Pacific.
Asia-Pacific Pain Management Drugs Market: Drivers
The Asia-Pacific pain management drugs market is witnessing robust growth as the prevalence of chronic pain conditions, such as arthritis, neuropathic pain, and cancer-related pain, continues to rise across the region. Increasing awareness among healthcare providers and patients about effective pain management therapies is driving higher adoption of analgesic medications. An aging population in countries like Japan, China, and India is contributing to a growing demand for long-term pain relief solutions. Technological advancements in drug formulations, including targeted therapies, biologics, and non-opioid alternatives, are enhancing treatment efficacy and safety profiles. Government initiatives aimed at improving healthcare access and infrastructure are further supporting market expansion and the availability of pain management therapies.
The rising preference for non-opioid pain relief medications, such as NSAIDs, acetaminophen, and cannabinoids, is shaping treatment trends and encouraging safer pain management practices. Expansion of healthcare access in rural and underserved areas, coupled with telemedicine adoption, is increasing the reach of pain management services. Economic growth and rising disposable incomes are enabling more patients to afford advanced pain therapies. Marketing campaigns emphasizing the benefits of comprehensive pain management and multidisciplinary approaches are boosting awareness among patients and physicians. As healthcare systems in the Asia-Pacific region continue to prioritize effective, accessible, and safe pain management, the market is poised for sustained growth and innovation.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/asia-pacific-pain-management-drugs-market?sp
Asia-Pacific Pain Management Drugs Market: Major Players
Sun Pharmaceutical Industries Ltd, Kalbe Farma, Hisamitsu Pharmaceutical Co., Inc., Torrent Pharmaceuticals Ltd, Dr. Reddy's Laboratories Ltd, Cipla Inc., Wockhardt Ltd, Bayer AG, Haleon Group of Companies, and Kenvue Brands LLC, among others.
Segment Covered in the Asia-Pacific Pain Management Drugs Market:
➥ By Drug Type: Non-Steroidal Anti-Inflammatory Drugs, Opioids, Corticosteroids, Muscle Relaxants, Anticonvulsant Drugs, Others
➥ By Indication: Arthritis Pain, Back Pain, Surgery Pain, Headaches & Migraine, Injury Pain, Cancer Pain, Fibromyalgia, Muscle Spasms, Menstrual Pain, Neuropathic Pain, Others
➥ By Mode of Prescription: Prescription-Based, Over-the-Counter
➥ By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Clinics, Online Pharmacies, Others
Research Process:
Both primary and secondary data sources have been used in the 55 Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Most Frequently Asked Questions in the Asia-Pacific Pain Management Drugs Market Research Industry:
➠ Who leads the Asia-Pacific Pain Management Drugs industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Asia-Pacific Pain Management Drugs market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Asia-Pacific Pain Management Drugs market growth?
➠ What are the dominant sales and distribution strategies in the Asia-Pacific Pain Management Drugs industry?
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=asia-pacific-pain-management-drugs-market
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia-Pacific Pain Management Drugs Market to hit US$31,304.67 million by 2033 | Major Companies 2025 - Sun Pharmaceutical Industries Ltd, Kalbe Farma, Hisamitsu Pharmaceutical Co. here
News-ID: 4179246 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Orthopedic Devices Market to Reach US$86.56 Billion by 2033 | CAGR 4.1% | North …
Market Overview
The Global Orthopedic Devices Market reached US$ 58.56 billion in 2024 and is projected to grow to US$ 86.56 billion by 2033, expanding at a CAGR of 4.1% during the forecast period 2025-2033. Orthopedic devices are specialized medical equipment designed to treat, support, and replace components of the musculoskeletal system, including bones, joints, and soft tissues. These devices are essential for managing conditions caused by trauma, congenital abnormalities, or…
Gene Therapy Market to Reach US$ 35.91 Billion by 2033 | CAGR 23.1% | North Amer …
Market Overview
The Global Gene Therapy Market reached US$ 4.80 billion in 2024 and is projected to grow to US$ 35.91 billion by 2033, expanding at a CAGR of 23.1% during the forecast period 2025-2033. The market is witnessing rapid growth, driven by advancements in genomics, biotechnology, and personalized medicine, and is transforming the treatment landscape for genetic disorders, rare diseases, and cancer. Significant R&D investments, strategic partnerships, and regulatory approvals…
United States Cloud Market 2031 | Growth Drivers, Key Players & Investment Oppor …
Market Size and Growth
The Global Cloud Market is estimated to have reached around USD 373 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 202 billion by 2031. The market is growing at a CAGR of 23.9% during the forecast period 2024-2031.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/cloud-market?sb
Key Development:
United States: Recent Cloud Computing Developments
✅ In…
High-Speed Steel (HSS) Market to Reach USD 5.1 Billion by 2032 | CAGR 5.76% | As …
Market Overview
The Global High-Speed Steel (HSS) Market reached US$ 3.1 billion in 2024 and is projected to grow to US$ 5.1 billion by 2032, expanding at a CAGR of 5.76% during the forecast period 2025-2032. The market growth is being driven by rising demand from key end-use industries such as automotive, aerospace, and industrial machinery, where high-speed steel is critical for cutting tools, drills, and machining operations due to its…
More Releases for Asia
Asia Private Equity Firm, Asia Private Equity Management, Asia Private Equity Se …
The private equity market in China has been rapidly growing in recent years. Private equity (PE) refers to the purchase of shares in a company that are not publicly traded on a stock exchange. PE firms typically target companies that are undervalued or in need of capital for growth, and aim to improve the company's operations and financial performance before selling it at a higher value.
https://boomingfaucet.com/
Asia Private Equity Consulting
E-mail:nolan@pandacuads.com
In China,…
South East Asia Business Jet Market And Top Key Players are Asia Corporate Jet, …
By 2022, the South East Asia Business Jet Markets estimated to reach US$ XX Mn, up from US$ XX Mn in 2016, growing at a CAGR of XX% during the forecast period. The Global Business Jet Market, currently at 21 million USD, contributes the highest share in the market and is poised to grow at the fastest rate in the future. The three broad categories of business jets are Small,…
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022.
23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property…
PEOPLEWAVE WINS ASIA TECH PODCAST PITCHDECK ASIA 2019 AWARDS
15 January 2019, Singapore – Peoplewave, Asia’s leading data-driven HR technology company, won the Asia Tech Podcast (ATP) Pitchdeck Asia 2019 Awards, being awarded “Startup Most Likely to Succeed in 2019".
The 2019 Pitchdeck Asia Awards is an opportunity for the Asian Startup Ecosystem to shine a spotlight on some of its best startups. The awards were decided by a public vote. More than 7,200 votes were cast by registered LinkedIn…
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia
Equipping Asia’s navies with the latest diving technology for asymmetric warfare and
operations
SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is
seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting…
Asia Diligence – Specialist Investigative Due Diligence for Asia & Beyond
Asia Diligence today announced the opening of its European Customer Services office in the United Kingdom. The office is to be managed by Steve Fowler and will focus on providing services to Asia Diligence’s European customers. Asia Diligence is also planning to open a US office in the near future, which will provide customer service to its US and North American clients.
Asked to comment on the move, Luke Palmer, the…
